Elizondo David R 4

4 · ATS MEDICAL INC · Filed Mar 17, 2010

Form 4

Period: 2010-03-15

VP-Research & Development

Transactions

Sale
Common Stock
2010-03-16$2.51/sh−14,760$37,048→ 82,953.075 total
Exercise/Conversion
Restricted Stock Units
2010-03-15−8,837→ 17,674 total
From: 2008-03-15Exp: 2012-03-15→ Common Stock (26,511 underlying)
Exercise/Conversion
Restricted Stock Units
2010-03-15−17,526→ 52,577 total
From: 2009-03-15Exp: 2013-03-15→ Common Stock (70,103 underlying)
Exercise/Conversion
Common Stock
2010-03-15+39,576→ 97,713.075 total
Exercise/Conversion
Restricted Stock Units
2010-03-15−13,213→ 52,852 total
From: 2010-03-15Exp: 2014-03-05→ Common Stock (66,065 underlying)

Holdings

Restricted Stock Units
From: 2009-07-30Exp: 2013-07-30→ Common Stock (40,000 underlying)
40,000
Restricted Stock Units
From: 2011-03-01Exp: 2015-03-01→ Common Stock (53,410 underlying)
53,410
Restricted Stock Units
From: 2007-09-29Exp: 2011-09-29→ Common Stock (20,000 underlying)
20,000
Restricted Stock Units
From: 2011-03-01Exp: 2015-03-01→ Common Stock (15,000 underlying)
15,000

Footnotes (6)

[F1]Includes shares acquired under the Employee Stock Purchase Plan as of January 31, 2010.
[F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2009.
[F3]1 unit for 1 share of Common Stock.
[F4]Vests in cumulative annual installments of 20% beginning the date shown.
[F5]Represents last vesting date.
[F6]Vests in 20% annual cumulative installments starting on the date shown; in the second year remaining vesting is subject to acceleration if certain performance criteria are met.

Documents

1 file